Clinical Study

Analysis of Serum and Urinal Copper and Zinc in Chinese Northeast Population with the Prediabetes or Diabetes with and without Complications

Table 5

Serum parameters in T2D patients treated with simvastatin.

Simvastatin ( )
PretreatmentPosttreatment

Cu (mg/L)1.18 (0.94–1.62)1.11 (0.99–1.64)0.765
UCu (μg/L)24.5 (19.0–31.5)21.5 (17.3–31.0)0.445
Zn (mg/L)0.65 (0.47–0.94)0.53 (0.43–0.77)0.108
UZn (mg/L)0.36 (0.17–0.57)0.25 (0.13–0.42)0.097
Zn/Cu0.58 (0.34–0.96)0.48 (0.39–0.68)0.592

Data presentation and abbreviations spelt out forms are the same as the description for Table 1. * versus pretreatment.